These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3291927)

  • 1. Tumour necrosis factor.
    Brenner MK
    Br J Haematol; 1988 Jun; 69(2):149-52. PubMed ID: 3291927
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumour necrosis factor: the decline and fall of a biological agent and its resurrection.
    Sleijfer S; Mulder NH
    Clin Oncol (R Coll Radiol); 1994; 6(2):127-32. PubMed ID: 8018571
    [No Abstract]   [Full Text] [Related]  

  • 3. Cachectin/tumor necrosis factor.
    Khan AS; Malik S
    J Pak Med Assoc; 1996 Jun; 46(6):137-40. PubMed ID: 8991374
    [No Abstract]   [Full Text] [Related]  

  • 4. [Tumor necrosis factor or cachectin].
    Marcheş F
    Rev Roum Virol; 1991; 42(1-2):97-104. PubMed ID: 1790126
    [No Abstract]   [Full Text] [Related]  

  • 5. [Tumor necrosis factor-alpha--biological and immunologic properties].
    Chciałowski A; Targowski T; Bajera I; Jahnz-Rózyk K
    Pol Merkur Lekarski; 1997 Jun; 2(12):392-5. PubMed ID: 9424334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in endogenous cytokines, adhesion molecules and platelets during cytokine-induced tumour necrosis.
    de Kossodo S; Moore R; Gschmeissner S; East N; Upton C; Balkwill FR
    Br J Cancer; 1995 Nov; 72(5):1165-72. PubMed ID: 7577463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour necrosis factor.
    Gifford GE; Flick DA
    Microbiol Sci; 1988 Apr; 5(4):104-7. PubMed ID: 3152764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor: is it a breakthrough?
    Stephens FO
    J Clin Oncol; 1996 Feb; 14(2):688-9. PubMed ID: 8636798
    [No Abstract]   [Full Text] [Related]  

  • 9. [Tumor necrosis factor].
    Herrmann F; Mertelsmann R
    Dtsch Med Wochenschr; 1989 Feb; 114(8):312-6. PubMed ID: 2646094
    [No Abstract]   [Full Text] [Related]  

  • 10. [Tumor necrosis factor-alpha--phase I and phase II clinical trials].
    Chciałowski A; Targowski T; Bajera I; Jahnz-Rózyk K
    Pol Merkur Lekarski; 1997 Jun; 2(12):396-9. PubMed ID: 9424335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor targeting with biotinylated tumor necrosis factor alpha: structure-activity relationships and mechanism of action on avidin pretargeted tumor cells.
    Corti A; Gasparri A; Sacchi A; Curnis F; Sangregorio R; Colombo B; Siccardi AG; Magni F
    Cancer Res; 1998 Sep; 58(17):3866-72. PubMed ID: 9731496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [TNF-alpha in neoplasms treatment--clinical application].
    Nowakowska-Zajdel E; Kokot T; Sosada K; Wierzgoń J; Klakla K; Cichocka M; Zubelewicz B; Muc-Wierzgoń M
    Pol Arch Med Wewn; 2002 Aug; 108(2):801-8. PubMed ID: 12476901
    [No Abstract]   [Full Text] [Related]  

  • 13. Tumour necrosis factor: clinical relevance.
    Jones AL; Selby P
    Cancer Surv; 1989; 8(4):817-36. PubMed ID: 2701729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expectations in the clinical application of human-recombinant cytokines. 3) Tumor necrosis factor and lymphotoxins].
    Kawakami M
    Nihon Rinsho; 1988 May; 46(5):1099-104. PubMed ID: 3137380
    [No Abstract]   [Full Text] [Related]  

  • 15. [Current developments in the field of sepsis: tumor necrosis factor (cachectin)].
    van Deventer SJ; Debets JM; Büller HR; ten Cate JW; van der Linden CJ; Buurman WA
    Ned Tijdschr Geneeskd; 1989 Jan; 133(1):17-9. PubMed ID: 2644550
    [No Abstract]   [Full Text] [Related]  

  • 16. [Advances in the study of tumor necrosis factor].
    Wang WZ
    Zhonghua Yi Xue Za Zhi; 1988 Feb; 68(2):112-5. PubMed ID: 3136877
    [No Abstract]   [Full Text] [Related]  

  • 17. Tumor necrosis factor and isolated hepatic perfusion: from preclinical tumor models to clinical studies.
    de Vries MR; ten Hagen TL; Marinelli AW; Eggermont AM
    Anticancer Res; 2003; 23(2C):1811-23. PubMed ID: 12820463
    [No Abstract]   [Full Text] [Related]  

  • 18. Tumor necrosis factor-alpha in the pathogenesis and treatment of cancer.
    Anderson GM; Nakada MT; DeWitte M
    Curr Opin Pharmacol; 2004 Aug; 4(4):314-20. PubMed ID: 15251122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour necrosis factor.
    Malik S; Balkwill FR
    Br Med J (Clin Res Ed); 1988 Apr; 296(6631):1214. PubMed ID: 3133019
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical probes using tumor necrosis factor in treatment of neoplastic diseases].
    Szczepanik A; Tabor J; Siedlar M
    Przegl Lek; 1994; 51(11):497-500. PubMed ID: 7871196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.